It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.
The company does not expect the outcome of this inspection to impact its plans
Zydus' Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy
The company is the Clinical Research Organisation of Caplin Point Laboratories
CuraTeQ Biologics is on track for filing a second oncology biosimilar
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
Assam is home to more than 1,700 species of medicinal plants
Surufatinib is the third potential new medicine discovered by the company to enter into clinical development in Japan
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
Subscribe To Our Newsletter & Stay Updated
